Lineage Cell Therapeutics (LCTX) Misses Q2 EPS by 10c, Beats on Revenue
Go back to Lineage Cell Therapeutics (LCTX) Misses Q2 EPS by 10c, Beats on Revenue| (NYSE: LCTX) | Delayed: 1.01 -0.01 (0.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.02 | 52 Week High | $ | |||
| Open | $1.02 | 52 Week Low | $ | |||
| Day High | $1.03 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $ | |||
| Volume | 910,446 | |||||
